Landscapes / Companies
UCB BIOSCIENCES, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 5 in all
Trials
1 active
12 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Fenfluramine HClnot checked |
— |
Approved | 6 Feb 2029Phase 3 trial completes | ||
| Next date | 6 Feb 2029 · Phase 3 trial completes | ||||
| Also tested for | Rett Syndrome | ||||
| Open drug page | |||||
About
- No active trial
- Brivaracetam, doxecitine and doxribtimine, Lacosamide, Olokizumab
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021